DIAGNOS Inc. Logo

DIAGNOS Inc.

ADK.V

(1.5)
Stock Price

0,27 CAD

-258.82% ROA

119.23% ROE

-9.56x PER

Market Cap.

31.445.365,00 CAD

-126.93% DER

0% Yield

-1029.81% NPM

DIAGNOS Inc. Stock Analysis

DIAGNOS Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

DIAGNOS Inc. Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a low debt to equity ratio (-118%), which means it has a small amount of debt compared to the ownership it holds

2 ROE

The stock's ROE exceeds expectations (113.12%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

3 PBV

The stock's low PBV ratio (-14.83x) suggests it's undervalued, making it an attractive opportunity for investors.

4 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

5 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

6 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

7 Graham Number

The company's Graham number indicates that it is overvalued compared to its stock price, suggesting a potentially unfavorable investment opportunity.

8 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

9 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

10 Buffet Intrinsic Value

The company's stock appears overvalued (0) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

11 ROA

The stock's ROA (-214.29%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

DIAGNOS Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

DIAGNOS Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Sell
4 Stoch RSI Buy

DIAGNOS Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

DIAGNOS Inc. Revenue
Year Revenue Growth
2001 7.000
2002 234.559 97.02%
2003 387.720 39.5%
2004 111.746 -246.97%
2005 709.187 84.24%
2006 775.720 8.58%
2007 1.863.176 58.37%
2008 1.885.956 1.21%
2009 358.073 -426.7%
2010 1.074.513 66.68%
2011 1.327.820 19.08%
2012 1.508.907 12%
2013 2.704.974 44.22%
2014 564.175 -379.46%
2015 981.480 42.52%
2016 2.390.051 58.93%
2017 1.612.821 -48.19%
2018 326.469 -394.02%
2019 326.469 0%
2020 331.517 1.52%
2021 267.073 -24.13%
2022 438.833 39.14%
2023 586.132 25.13%
2023 170.158 -244.46%
2024 146.760 -15.94%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

DIAGNOS Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2001 1.442.201
2002 192.919 -647.57%
2003 -4.557 4333.46%
2004 784.103 100.58%
2005 179.584 -336.62%
2006 101.246 -77.37%
2007 193.817 47.76%
2008 674.242 71.25%
2009 618.212 -9.06%
2010 614.125 -0.67%
2011 793.959 22.65%
2012 831.564 4.52%
2013 0 0%
2014 0 0%
2015 1.073.127 100%
2016 0 0%
2017 0 0%
2018 922.493 100%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 1.082.223 100%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

DIAGNOS Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2001 0
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 2.759.984 100%
2012 2.839.323 2.79%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

DIAGNOS Inc. EBITDA
Year EBITDA Growth
2001 -2.878.677
2002 -558.885 -415.08%
2003 -33.956 -1545.91%
2004 -1.774.480 98.09%
2005 -560.214 -216.75%
2006 -711.982 21.32%
2007 -347.399 -104.95%
2008 -1.967.972 82.35%
2009 -1.740.106 -13.09%
2010 -1.457.141 -19.42%
2011 -1.787.951 18.5%
2012 -1.284.238 -39.22%
2013 -1.583.817 18.92%
2014 -2.624.481 39.65%
2015 -2.640.843 0.62%
2016 -1.781.516 -48.24%
2017 -2.655.314 32.91%
2018 -2.684.860 1.1%
2019 -2.686.342 0.06%
2020 -2.605.599 -3.1%
2021 -1.931.701 -34.89%
2022 -2.448.637 21.11%
2023 -1.767.144 -38.56%
2023 -2.476.610 28.65%
2024 -2.184.640 -13.36%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

DIAGNOS Inc. Gross Profit
Year Gross Profit Growth
2001 7.000
2002 234.559 97.02%
2003 387.720 39.5%
2004 111.746 -246.97%
2005 709.187 84.24%
2006 775.720 8.58%
2007 1.863.176 58.37%
2008 1.885.956 1.21%
2009 358.073 -426.7%
2010 1.049.563 65.88%
2011 1.223.279 14.2%
2012 1.459.638 16.19%
2013 464.533 -214.22%
2014 -541.432 185.8%
2015 -203.506 -166.05%
2016 719.101 128.3%
2017 290.895 -147.2%
2018 -759.372 138.31%
2019 -759.372 0%
2020 -473.455 -60.39%
2021 -347.530 -36.23%
2022 -418.296 16.92%
2023 -183.492 -127.96%
2023 -837.939 78.1%
2024 -356.452 -135.08%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

DIAGNOS Inc. Net Profit
Year Net Profit Growth
2001 -3.182.617
2002 -794.917 -300.37%
2003 -130.059 -511.2%
2004 -1.746.088 92.55%
2005 -581.864 -200.09%
2006 -617.133 5.71%
2007 -398.085 -55.03%
2008 -2.079.903 80.86%
2009 -1.910.838 -8.85%
2010 -1.074.271 -77.87%
2011 -2.192.979 51.01%
2012 -2.043.717 -7.3%
2013 -1.640.784 -24.56%
2014 -2.827.588 41.97%
2015 -3.192.431 11.43%
2016 -5.420.641 41.11%
2017 -2.897.165 -87.1%
2018 -3.839.056 24.53%
2019 -3.839.056 0%
2020 -3.382.873 -13.49%
2021 -2.051.303 -64.91%
2022 -2.608.218 21.35%
2023 -2.082.840 -25.22%
2023 -3.120.582 33.25%
2024 -2.866.624 -8.86%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

DIAGNOS Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2001 -1
2002 -1 0%
2003 0 0%
2004 -1 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

DIAGNOS Inc. Free Cashflow
Year Free Cashflow Growth
2001 -2.466.929
2002 -816.350 -202.19%
2003 -104.101 -684.19%
2004 -1.827.638 94.3%
2005 -1.291.196 -41.55%
2006 -958.677 -34.69%
2007 -193.286 -395.99%
2008 -2.001.575 90.34%
2009 -1.545.643 -29.5%
2010 -1.548.553 0.19%
2011 -1.974.952 21.59%
2012 -2.093.318 5.65%
2013 -1.235.068 -69.49%
2014 -2.901.851 57.44%
2015 -2.437.042 -19.07%
2016 -2.049.334 -18.92%
2017 -2.514.543 18.5%
2018 -2.362.004 -6.46%
2019 -2.362.004 0%
2020 -2.655.834 11.06%
2021 -1.398.981 -89.84%
2022 -2.068.955 32.38%
2023 -2.420.795 14.53%
2023 -342.857 -606.07%
2024 -840.509 59.21%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

DIAGNOS Inc. Operating Cashflow
Year Operating Cashflow Growth
2001 -2.272.906
2002 -805.060 -182.33%
2003 -103.188 -680.19%
2004 -1.818.447 94.33%
2005 -1.236.112 -47.11%
2006 -876.299 -41.06%
2007 -547 -160100.91%
2008 -1.747.464 99.97%
2009 -1.506.911 -15.96%
2010 -1.408.841 -6.96%
2011 -1.906.675 26.11%
2012 -2.008.399 5.06%
2013 -1.213.753 -65.47%
2014 -2.866.405 57.66%
2015 -2.233.132 -28.36%
2016 -1.786.903 -24.97%
2017 -2.243.595 20.36%
2018 -2.319.721 3.28%
2019 -2.319.721 0%
2020 -2.640.705 12.16%
2021 -1.356.799 -94.63%
2022 -2.037.943 33.42%
2023 -2.409.941 15.44%
2023 -339.222 -610.43%
2024 -840.509 59.64%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

DIAGNOS Inc. Capital Expenditure
Year Capital Expenditure Growth
2001 194.023
2002 11.290 -1618.54%
2003 913 -1136.58%
2004 9.191 90.07%
2005 55.084 83.31%
2006 82.378 33.13%
2007 192.739 57.26%
2008 254.111 24.15%
2009 38.732 -556.08%
2010 139.712 72.28%
2011 68.277 -104.63%
2012 84.919 19.6%
2013 21.315 -298.4%
2014 35.446 39.87%
2015 203.910 82.62%
2016 262.431 22.3%
2017 270.948 3.14%
2018 42.283 -540.8%
2019 42.283 0%
2020 15.129 -179.48%
2021 42.182 64.13%
2022 31.012 -36.02%
2023 10.854 -185.72%
2023 3.635 -198.6%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

DIAGNOS Inc. Equity
Year Equity Growth
2001 -325.745
2002 -264.638 -23.09%
2003 -128.754 -105.54%
2004 161.611 179.67%
2005 793.681 79.64%
2006 1.421.609 44.17%
2007 4.205.976 66.2%
2008 2.410.056 -74.52%
2009 1.981.852 -21.61%
2010 1.182.179 -67.64%
2011 2.343.491 49.55%
2012 1.745.943 -34.22%
2013 346.950 -403.23%
2014 -224.850 254.3%
2015 -3.148.961 92.86%
2016 -5.575.175 43.52%
2017 -3.636.685 -53.3%
2018 -5.082.599 28.45%
2019 -5.082.599 0%
2020 1.819.171 379.39%
2021 1.132.153 -60.68%
2022 -113.510 1097.4%
2023 -3.051.848 96.28%
2023 -1.209.693 -152.28%
2024 -2.438.697 50.4%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

DIAGNOS Inc. Assets
Year Assets Growth
2001 346.870
2002 250.856 -38.27%
2003 711.902 64.76%
2004 376.770 -88.95%
2005 964.273 60.93%
2006 1.601.670 39.8%
2007 4.871.677 67.12%
2008 2.662.755 -82.96%
2009 2.273.691 -17.11%
2010 1.513.768 -50.2%
2011 2.651.647 42.91%
2012 2.221.748 -19.35%
2013 1.577.927 -40.8%
2014 1.172.262 -34.61%
2015 1.270.622 7.74%
2016 1.309.245 2.95%
2017 1.524.247 14.11%
2018 1.207.141 -26.27%
2019 1.207.141 0%
2020 2.433.947 50.4%
2021 1.950.342 -24.8%
2022 1.541.581 -26.52%
2023 663.787 -132.24%
2023 805.949 17.64%
2024 1.103.542 26.97%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

DIAGNOS Inc. Liabilities
Year Liabilities Growth
2001 672.615
2002 515.494 -30.48%
2003 840.656 38.68%
2004 215.159 -290.71%
2005 170.592 -26.12%
2006 180.061 5.26%
2007 665.701 72.95%
2008 252.699 -163.44%
2009 291.839 13.41%
2010 331.589 11.99%
2011 308.156 -7.6%
2012 475.805 35.23%
2013 1.230.977 61.35%
2014 1.397.112 11.89%
2015 4.419.583 68.39%
2016 6.884.420 35.8%
2017 5.160.932 -33.39%
2018 6.289.740 17.95%
2019 6.289.740 0%
2020 614.776 -923.09%
2021 818.189 24.86%
2022 1.655.091 50.57%
2023 3.715.635 55.46%
2023 2.015.642 -84.34%
2024 3.542.239 43.1%

DIAGNOS Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0.04
Price to Earning Ratio
-9.56x
Price To Sales Ratio
113.38x
POCF Ratio
-10.9
PFCF Ratio
-12.52
Price to Book Ratio
-11.19
EV to Sales
124.48
EV Over EBITDA
-15.22
EV to Operating CashFlow
-13.79
EV to FreeCashFlow
-13.75
Earnings Yield
-0.1
FreeCashFlow Yield
-0.08
Market Cap
0,03 Bil.
Enterprise Value
0,03 Bil.
Graham Number
0.16
Graham NetNet
-0.04

Income Statement Metrics

Net Income per Share
-0.04
Income Quality
0.88
ROE
1.19
Return On Assets
-2.59
Return On Capital Employed
2.11
Net Income per EBT
1
EBT Per Ebit
1.19
Ebit per Revenue
-8.63
Effective Tax Rate
0.03

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.6
Gross Profit Margin
-1.99
Operating Profit Margin
-8.63
Pretax Profit Margin
-10.3
Net Profit Margin
-10.3

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.03
Free CashFlow per Share
-0.03
Capex to Operating CashFlow
-0
Capex to Revenue
0.03
Capex to Depreciation
0.06
Return on Invested Capital
-3.52
Return on Tangible Assets
-2.59
Days Sales Outstanding
253.66
Days Payables Outstanding
77.95
Days of Inventory on Hand
0
Receivables Turnover
1.44
Payables Turnover
4.68
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,01
Book Value per Share
-0,03
Tangible Book Value per Share
-0.03
Shareholders Equity per Share
-0.03
Interest Debt per Share
0.05
Debt to Equity
-1.27
Debt to Assets
2.8
Net Debt to EBITDA
-1.36
Current Ratio
0.39
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
-1132245
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0.1

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

DIAGNOS Inc. Dividends
Year Dividends Growth

DIAGNOS Inc. Profile

About DIAGNOS Inc.

DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. The company was founded in 1998 and is headquartered in Brossard, Canada.

CEO
Mr. Andre Larente
Employee
16
Address
7005 Taschereau Boulevard
Brossard, J4Z 1A7

DIAGNOS Inc. Executives & BODs

DIAGNOS Inc. Executives & BODs
# Name Age
1 Mr. Andre Larente
Chief Executive Officer, President & Executive Chairman
70
2 Mr. Marc-André Massue
Vice President of Finance, Chief Financial Officer & Secretary
70
3 Mr. Yves-Stéphane Couture
Chief Operating Officer
70

DIAGNOS Inc. Competitors